October 29, 2021
A congressional letter on cBHT needs signatures
In an effort to head off any plans FDA might have to restrict compounded hormones, U.S. representatives Jaime Herrera-Butler (R-WA) and Jennifer Wexton (D-VA) are circulating a “Dear Colleague” memo to the rest of the House. They’re asking for signatures on a letter to FDA Acting Commissioner Janet Woodcock that reminds her of the importance of cBHT, as well as the adverse consequences to the more than 2.5 million women in the U.S. who rely on it, should FDA restrict access based on that debunked NASEM report.
A bipartisan letter is a start, but they’ll need a lot more signatures for it to have an impact.
You can — you need to — help. Contact your member of Congress and ask them to co-sign the “Bipartisan Letter to Protect Women’s Access to Compounded Hormones” circulated by representatives Herrera-Butler and Wexton.
And if you’re coming to Compounders on Capitol Hill next week, getting other representatives to sign that letter will be one of our priorities. Reach out to your representative now to pave the way for those CCH conversations!
